ShareHope Medicine (8403) Monthly Revenue

Market: TPEx (OTC) · Industry: Biotech & Medical · 盛弘

ShareHope Medicine (8403) reported revenue of NT$362.6 million for Oct 2026, -5.9% year on year and -15.3% from the previous month. Revenue for Jan–Oct 2026 was NT$3.86 billion (+6.8% year on year).

In Oct 2026, it ranked No. 26 by revenue among 160 Biotech & Medical companies.

Monthly revenue chart

Oct 2024 NT$370.8 million24/10Nov 2024 NT$366.1 millionDec 2024 NT$374.5 millionJan 2025 NT$352 millionFeb 2025 NT$303.5 million25/02Mar 2025 NT$392.1 millionApr 2025 NT$354.6 millionMay 2025 NT$335.3 millionJun 2025 NT$386.7 million25/06Jul 2025 NT$372.7 millionAug 2025 NT$366.4 millionSep 2025 NT$368.2 millionOct 2025 NT$385.5 million25/10Nov 2025 NT$344.2 millionDec 2025 NT$396 millionJan 2026 NT$385.2 millionFeb 2026 NT$293.6 million26/02Mar 2026 NT$395.9 millionApr 2026 NT$385 millionMay 2026 NT$367.6 millionJun 2026 NT$435.1 million26/06Jul 2026 NT$412.2 millionAug 2026 NT$397.9 millionSep 2026 NT$428.1 millionOct 2026 NT$362.6 million26/10

Hover over (or tap) a bar to see that month’s revenue.

Monthly revenue history

MonthRevenueYoYMoM
Oct 2026NT$362.6 million-5.9%-15.3%
Sep 2026NT$428.1 million+16.3%+7.6%
Aug 2026NT$397.9 million+8.6%-3.5%
Jul 2026NT$412.2 million+10.6%-5.3%
Jun 2026NT$435.1 million+12.5%+18.4%
May 2026NT$367.6 million+9.7%-4.5%
Apr 2026NT$385 million+8.6%-2.7%
Mar 2026NT$395.9 million+1.0%+34.8%
Feb 2026NT$293.6 million-3.3%-23.8%
Jan 2026NT$385.2 million+9.4%-2.7%
Dec 2025NT$396 million+5.7%+15.0%
Nov 2025NT$344.2 million-6.0%-10.7%
Oct 2025NT$385.5 million+4.0%+4.7%
Sep 2025NT$368.2 million-2.9%+0.5%
Aug 2025NT$366.4 million-4.5%-1.7%
Jul 2025NT$372.7 million-2.7%-3.6%
Jun 2025NT$386.7 million-0.4%+15.4%
May 2025NT$335.3 million-10.6%-5.5%
Apr 2025NT$354.6 million+6.6%-9.6%
Mar 2025NT$392.1 million+20.3%+29.2%
Feb 2025NT$303.5 million+10.6%-13.8%
Jan 2025NT$352 million-5.4%-6.0%
Dec 2024NT$374.5 million-3.1%+2.3%
Nov 2024NT$366.1 million+8.4%-1.3%
Oct 2024NT$370.8 million+8.0%-2.2%

Jan–Oct 2026 cumulative: NT$3.86 billion (+6.8% YoY)

History covers months since this site began collecting, plus prior-month and prior-year figures in each release. It grows every month.

Other Biotech & Medical companies

Compare with peers: ShareHope Medicine vs PEC / ShareHope Medicine vs Lotus Pharm / ShareHope Medicine vs Bora

CompanyRevenueYoY
PEC6446NT$2.84 billion+102.0%
Lotus Pharm1795NT$2.13 billion-22.5%
Bora6472NT$1.99 billion+15.9%
Great Tree Pharmacy6469NT$1.67 billion+1.5%
EXCELSIOR4104NT$1.02 billion+38.6%
PEGAVISION6491NT$793 million+13.0%
Synmosa Biopharma4114NT$766.6 million+41.2%
Y.S.H.3705NT$749.4 million+4.4%

See also

← All Taiwan listed & OTC companies

Sources: Taiwan Stock Exchange, monthly revenue of listed companies (Government Open Data Platform); Taipei Exchange, monthly revenue of OTC companies (TPEx OpenAPI); historical months from MOPS. Amounts in New Taiwan dollars. Changes calculated by this site from the source figures. Not investment advice. Updated: 2026-11-16